Peritoneal cell populations during tumour injection
- PMID: 7085002
Peritoneal cell populations during tumour injection
Abstract
The response of peritoneal cells to the SL2 lymphoma was studied in immunized and non-immunized mice to elucidate further the cellular events that lead to tumour rejection in an allogeneic and a syngeneic tumour system. Anti-tumor immunity was induced by intraperitoneal injection of normal, irradiated or mitomycin-C treated tumour cells. Four different immunization schedules were tested. The response of the peritoneal cells was investigated by studying the peritoneal cell population kinetics (appearance and/or disappearance of various cell types e.g. mononuclear phagocytes, lymphocytes, PMNS and mast cells). Total cell counts were done using phase contrast microscopy, differential cell counts were done on cytocentrifuge slides, stained with May Grünwald-Giemsa. The activity of the lysosomal enzyme beta-glucuronidase present in mononuclear phagocytes was also studied. The results indicated that the composition and morphology of the cellular fraction of the peritoneal exudate changes quite dramatically during tumour rejection. Especially the beta-glucuronidase activity of the mononuclear phagocytes line varies significantly. The observed changes in the cellular population depended upon the dose of tumour cells injected i.p. No significant differences were observed between the peritoneal cell populations of mice grafted i.p. with irradiated or with mitomycin-C treated tumour cells. On the other hand when mice previously immunized with three injections with 10 irradiated or mitomycin-C treated tumour cells were challenged i.p. with various doses of tumour cells, the immune potency against the tumour is greater after previous immunization with irradiated SL2 cells than after immunization with mitomycin-C treated tumour cells.
Similar articles
-
Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.Cancer Res. 1977 Feb;37(2):507-13. Cancer Res. 1977. PMID: 832275
-
Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.J Clin Lab Immunol. 1986 Feb;19(2):83-9. J Clin Lab Immunol. 1986. PMID: 3083105
-
Quantitative and ultrastructural changes of peritoneal macrophages in immunized rats after intraperitoneal injection of Novikoff hepatoma.J Natl Cancer Inst. 1980 Dec;65(6):1273-83. J Natl Cancer Inst. 1980. PMID: 6933273
-
The peritoneal cavity as a site for studying cell-cell and cell-virus interactions.J Reticuloendothel Soc. 1973 Nov;14(5):462-512. J Reticuloendothel Soc. 1973. PMID: 4587147 Review. No abstract available.
-
Phagocytes and worms: David and Goliath revisited.Rev Infect Dis. 1982 May-Jun;4(3):698-714. doi: 10.1093/clinids/4.3.698. Rev Infect Dis. 1982. PMID: 6750739 Review. No abstract available.
Cited by
-
Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipients.Cancer Immunol Immunother. 1983;16(2):72-6. doi: 10.1007/BF00199234. Cancer Immunol Immunother. 1983. PMID: 6559103 Free PMC article.
-
Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection.Cancer Immunol Immunother. 1989;30(1):28-33. doi: 10.1007/BF01665027. Cancer Immunol Immunother. 1989. PMID: 2598173 Free PMC article.
-
Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.Cancer Immunol Immunother. 1987;24(1):25-36. doi: 10.1007/BF00199829. Cancer Immunol Immunother. 1987. PMID: 3493070 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical